BackgroundBackground: Anxiety is a major complication in Parkinson's disease (PD). Many PD patients experience clinically significant anxiety not meeting Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) anxiety disorder criteria. This atypical anxiety (anxiety disorder not otherwise specified [NOS]) is often under-recognized and its diagnosis is underdeveloped. Objectives Objectives: This study aimed to identify the demographic, psychiatric, and clinical characteristics of anxiety disorder NOS in PD. Methods Methods: A cross-sectional design studied a convenience sample of 184 PD patients without dementia recruited from neurology outpatient clinics. A semi-structured interview using DSM-IV criteria categorized PD patients into current anxiety disorder NOS (n = 28), DSM-IV anxiety disorders (n = 42) or no anxiety (n = 86) groups. Logistic regression modeling identified characteristics associated with the anxiety disorder NOS group compared to DSM-IV anxiety and no anxiety groups. Results Results: The anxiety disorder NOS group was associated with motor complications of PD therapy, episodic, persistent and social anxiety symptoms, depression, non-motor experiences of daily living, poor quality of life, and female sex compared to the no anxiety group. Compared to DSM-IV anxiety, those with anxiety disorder NOS demonstrated greater global cognitive impairment, more severe motor complications of PD therapy, a greater severity and functional impact of dyskinesias, and greater complexity of motor fluctuations. Persistent, episodic, and social anxiety symptoms did not significantly differ between anxiety disorder NOS and DSM-IV anxiety groups. Conclusions Conclusions: These findings suggest that PD-specific symptoms characterize anxiety in a subgroup of PD patients who do not fulfill DSM-IV criteria for anxiety disorders.Anxiety is one of the most poorly understood and undertreated non-motor symptoms in Parkinson's disease (PD). 1 The prevalence of Diagnostic and Statistical Manual of Mental Disorders (DSM) anxiety disorders in PD is estimated to be 31% 2 ; 3 times more prevalent than the general elderly population. 3 However, a high proportion (13.3%) of PD patients experience clinically significant anxiety that does not meet DSM criteria for a diagnosable disorder. 2 Patients in this atypical category are diagnosed with unspecified anxiety disorder according to the DSM Fifth Edition (DSM-5), or anxiety disorder not otherwise specified (NOS) according to earlier editions. We used DSM Fourth Edition (DSM-IV) criteria and "anxiety disorder NOS" terminology as our study commenced in 2011 before the availability of the DSM-5. Our conclusions are not affected by changes in diagnostic criteria. Despite its prevalence, nearly 70% of PD patients with anxiety disorder NOS are untreated. 1 Accordingly, anxiety is considered 1 of the top 3 unmet needs in over 40% of PD patients 4 and avenues to reducing anxiety are high research priorities. 5
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.